3 Future direction Current and forthcoming research on GLP-1 RAs in pediatric obesity will focus on new agents, optimal dosing regimens, long-term outcomes, and comprehensive safety monitoring
40,41 A study using nationwide registers in Nordic countries showed that with an additional adjustment for laboratory results (glycated hemoglobin, albuminuria, eGFR), there was no difference in the risk of AF between SGLT2i users and GLP-1RA users in Swedish cohort (HR=0.90 [95% CI: 0.79 to 1.01]) and in Danish cohort (HR=0.92 [95% CI: 0.79 to 1.08])
14.1 Epilepsy The efficacy of divalproex sodium in reducing the incidence of complex partial seizures (CPS) that occur in isolation or in association with other seizure types was established in two controlled trials
Compounds such as GHK-Cu have been developed to explore signalling pathways and peptide interactions in controlled laboratory environments
GHK-Cu 50mg is typically provided as a lyophilized (freeze-dried) powder designed for laboratory research applications
Another study tracking 85 patients found that 65.38% experienced weight gain within the same timeframe, with an average weight regain of 24.4% over 12 months
